risks semaglutide Semaglutide: What we know about safety and cancer risk Tirzepatide vs. Semaglutide: What You
Description
GLP-1 agonists are regularly prescribed by doctors for patients with Type 2 Diabetes. And now theyre the next big thing in the weight loss world.
Longitudinal Targeted Minimum Loss-based Estimation, a method that adjusts for both baseline and time-varying confounding, was used to estimate absolute risks of cardiovascular outcomes under sustained use of GLP1-RA and DPP 4i (active comparator), adjusting for baseline and time-varying confounding
Join NPR Plus.Follow Brittany on Instagram: @bmluseFor handpicked podcast recommendations every week, subscribe to NPRs Pod Club newsletter at npr.org/podclub.
Keep yourself financially updated with our monthly economic reports and newsletters.
Comparing GLP-1 injections vs pills for weight loss
